公开(公告)号：US20230338654A1

公开(公告)日：2023-10-26

申请号：US18139427

申请日：2023-04-26

Applicant: Dexcom, Inc.

Inventor： Stephen D. Patek ,  Matthew S. Gerber ,  Enrique Campos-Nanez ,  Thibault Gautier ,  Leah Ziegler

IPC: A61M5/172 ,  A61M5/168

CPC classification number: A61M5/1723 ,  A61M5/16877 ,  A61M2202/0486 ,  A61M2205/50

Abstract: A continuous glucose monitor (CGM)-driven basal insulin titration system and method for patients with Type 2 Diabetes can be adapted to the needs and concerns of subjects just starting on basal insulin therapy. The method uses as inputs historical CGM data, basal insulin dose information, reports of hypoglycemia, and past recommendations and generates an adjusted insulin dose along with a report advising whether to continue the titration process, or to stop. The method can generate a new recommendation on a regular basis (e.g., each day) until it determines an adequate, consistent dose size.

公开(公告)号：US20240058532A1

公开(公告)日：2024-02-22

申请号：US18383133

申请日：2023-10-24

Applicant: Dexcom, Inc.

Inventor： Stephen D. Patek ,  Matthew S. Gerber ,  Enrique Campos-Nanez ,  Thibault Gautier ,  Leah Ziegler

IPC: A61M5/172 ,  A61M5/168

CPC classification number: A61M5/1723 ,  A61M5/16877

Abstract: A continuous glucose monitor (CGM)-driven basal insulin titration system and method for patients with Type 2 Diabetes can be adapted to the needs and concerns of subjects just starting on basal insulin therapy. The method uses as inputs historical CGM data, basal insulin dose information, reports of hypoglycemia, and past recommendations and generates an adjusted insulin dose along with a report advising whether to continue the titration process, or to stop. The method can generate a new recommendation on a regular basis (e.g., each day) until it determines an adequate, consistent dose size.